An overview of how data from the Centers for Medicare & Medicaid Services' CROWNWeb system could provide additional support.
Novel assay can distinguish between oxidized and nonoxidized forms of parathyroid hormone.
Agency releases a video, a poster, and a pocket guide to help providers and patients prevent development of infectious complications in patients undergoing hemodialysis.
Decreasing TSAT and higher ESA doses are associated with increasing platelet counts.
Declines in serum phosphorus over time may improve survival.
Worsening or resistant hyperphosphatemia may be an under-appreciated consequence of secondary hyperparathyroidism.
Atorvastatin did not reduce the risk of a combined endpoint of cardiovascular death, MI, and stroke.
Levels declined significantly from 7.2 to 5.0 mg/dL, data show.
Researchers speculate patients on peritoneal dialysis are more physically active than those on HD, and this may lower diabetes risk.
These include use of lower ESA doses and hemoglobin levels.
Patients with levels below 10 g/dL had the highest unadjusted mortality and all-cause hospitalization rates.
Results show an increased risk of mortality and hospitalizations compared with late starts.
Study of patients new to dialysis also demonstrates an increase in the likelihood of hospitalization.
Low phosphorus increases all-cause and cardiovascular mortality only among the elderly.
Changes in body weight in advance of dialysis initiation are associated with significantly increased one-year mortality among nursing home residents.
Each 10 cc increment in epicardial adipose tissue is associated with a significant 6% increased risk of death in patients newly started on hemodialysis.
Vascular access-related bloodstream infections were 13 times more likely to develop in patients with than without central venous catheters.
They have a higher inpatient mortality risk and longer lengths of stay compared with those admitted on weekdays.
Trend may be due in part to changes in the management of bone mineral disease, researchers speculate.
Study finds that 22% of patients did not have the right dose of antibiotics during their time on continuous venovenous hemodialysis.
Reduced circulating levels are significantly associated with poor sleep quality in HD patients.
Surgeons need to preoperatively carefully analyze inclusion criteria, survival rates
Soluble ferric pyrophosphate is a unique carbohydrate-free formulation administrated via dialysate.
Researchers report that elderly end-stage renal disease patients using catheters for dialysis may have the highest risk of dying prematurely.
Numerous studies have found that greater physician caseloads are associated with better patient outcomes.
Nephrologists with fewer patients had lower patient mortality rates.
Severe fluid overload in patients with advanced CKD increases by threefold the likelihood of initiation of renal replacement therapy.
In a study, 55% of male hemodialysis patients had low testosterone.
Declines in mid-arm circumference and skinfold thickness herald an increased death risk, especially in normal-weight patients.
A new study has found that many nephrologists are reluctant to tell their seriously ill end-stage renal disease patients the true estimates.